TCL Archive AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm May 8, 2013
TCL Archive NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ October 24, 1997
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive DCPC Bard Approves Concepts For New Minority Enhancement Awards Program, Two RFA Reissues January 22, 1988